The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...